Royalty says it will pay $12.50 in cash for each share of Elan. 
Intercell Announces Pediatric Approval of its Japanese Encephalitis... 
Peregrine rises on agreement for late-stage study WASHINGTON (AP) —... 
Special Reports
Pharmalot
Last week, Ranbaxy Laboratories agreed to pay $500 million to settle criminal and civil charges in the US for a serious...
In a setback to autism research, a small biotech has placed its activities on hold and discontinued a clinical trial...
Last week, the European Medicines Agency completed a review of the Diane 35 acne pill sold by Bayer, which is also...
Our experts are on hand to offer industry-specific advice.